CCXI Chemocentryx Inc

ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.

$62.47  -4.33 (-6.48%)
As of 03/03/2021 15:59:44 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Mid cap
Health Care
Biotechnology
USA
USA
02/08/2012
69,613,267
426,855
$4,650,166,236
0.00%
SEC Edgar Online
10-Q
10-K
16383L106
US16383L1061
B6ZL968

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-113.40
11.40
66.40
-10.13%
-58.55%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy